NA
ELV icon

Navellier & Associates’s Elevance Health ELV Stock Holding History

Navellier & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,069
Closed -$235K – 314
2018
Q1 		$235K Buy
+1,069
New +$251K 0.04% 256
2016
Q1 		– Sell
-196,721
Closed -$27.4M – 269
2015
Q4 		$27.4M Sell
196,721
-22,958
-10% -$3.16M 3.02% 4
2015
Q3 		$30.8M Sell
219,679
-2,986
-1% -$449K 3.1% 3
2015
Q2 		$36.5M Buy
222,665
+197
+0.1% +$31.5K 3.21% 5
2015
Q1 		$34.4M Sell
222,468
-285,501
-56% -$40.6M 3.11% 6
2014
Q4 		$63.8M Sell
507,969
-22,439
-4% -$2.77M 3.19% 9
2014
Q3 		$63.4M Buy
+530,408
New +$60.8M 3.19% 7

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Navellier & Associates's ELV Position: Q2 2018 in Review

Navellier & Associates sold out of Elevance Health (ELV) in Q2 2018, closing a stake of 1,069 shares — an estimated $235K sold.

Navellier & Associates first reported a position in ELV in Q3 2014 and held it in 7 quarters. The position peaked at $63.8M in Q4 2014. 935 funds tracked by Wall St. Rank hold ELV as of Q2 2018.

  • Navellier & Associates reported no remaining Elevance Health position as of Q2 2018 after selling out during the quarter.
  • Navellier & Associates sold 1,069 Elevance Health shares in Q2 2018, an estimated $235K.
  • Navellier & Associates first reported a position in Elevance Health in Q3 2014 and held it in 7 quarters.
  • Navellier & Associates's Elevance Health position peaked at $63.8M in Q4 2014.
  • 935 funds tracked by Wall St. Rank held Elevance Health as of Q2 2018.

Based on Navellier & Associates's 13F filing for Q2 2018, filed 6 Aug 2018.